Glenmark Pharma zooms 10% on positive management commentary

Glenmark Pharma aims to turn cash positive by the end of the current fiscal. The drugmaker also expects respiratory and injectables to be the major contributors in FY25

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *